From biologics to cell and gene therapy, our precision-engineered solutions ensure the safe, compliant, and reliable transport of critical healthcare products
Here's what's happening behind the scenes and what agents need to know to help clients navigate this new underwriting landscape
[10, 11] SGLT1 inhibition presents itself as a potential alternative given its intestinal prevalence and prevention of dietary glucose uptake with a number of drugs such as LX2761, TP0438836, and Mizagliflozin in development
Confirm whether your insurer has a national PA that transfers or whether AZ-specific re-authorization is needed
How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test may help provide context about your predisposition in key GLP-1 receptor and metabolic pathwaysincluding GLP1R rs6923761, GIPR rs1800437, and FTO rs9939609 variants